Literature DB >> 22423672

Recurrence of primary aldosteronism after percutaneous ethanol injection.

Fan-Chi Chang1, Kao-Lang Liu, Kuo-How Huang, Vin-Cent Wu, Yen-Hung Lin, Yung-Ming Chen, Kwan-Dun Wu.   

Abstract

Adrenalectomy is the definite treatment for aldosterone-producing adenoma (APA). Percutaneous ethanol or acetic acid injection with computed tomography (CT) guidance has been described as a safe, noninvasive, and effective alternative treatment modality in patients with high surgical risk. We report on a man who was 49 years of age and presented with treatment-resistant hypertension and was later diagnosed with APA. CT-guided percutaneous ethanol injection (PEI) was performed for this high surgical risk patient. He had aldosteronism recurrence 4 years after the ethanol injection, so a second PEI was performed. The tumor size was reduced and his blood pressure was normalized. Therefore, we suggest that clinicians should closely check aldosterone to renin ration and potassium level if percutaneous chemical ablation is considered in functioning adrenal adenomas.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22423672     DOI: 10.1016/j.jfma.2012.01.009

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  1 in total

1.  Long-term Results after CT-Guided Percutaneous Ethanol Ablation for the Treatment of Hyperfunctioning Adrenal Disorders.

Authors:  Nathan Elie Frenk; Fernando Sebastianes; Antonio Marcondes Lerario; Maria Candida Barisson Villares Fragoso; Berenice Bilharinho Mendonca; Marcos Roberto de Menezes
Journal:  Clinics (Sao Paulo)       Date:  2016-10-01       Impact factor: 2.365

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.